Results 231 to 240 of about 89,791 (356)

Partial Cystectomy and Substitution Cystoplasty for Urinary Bladder Involvement of Colorectal Cancer.

, 1995
Kenjiro Kotake, Yasuo Koyama, Junichirou Nasu   +2 more
openalex   +2 more sources

Cystectomy with orthotopic reconstruction following radical retropubic prostatectomy [PDF]

, 2004
Ari Miotto, Marcos F. Dall’Oglio, Miguel Srougi   +2 more
openalex   +1 more source

Long‐term quality of life in patients with bladder cancer following radical cystectomy

BJU International, Volume 135, Issue 4, Page 675-683, April 2025.
Objectives To investigate changes in quality of life (QoL) up to 8 years after radical cystectomy (RC) and compare QoL after RC with a gender‐ and age‐matched Dutch normative population. Furthermore, we aimed to identify patient characteristics associated with QoL and QoL trajectories after RC.
Emine Akdemir, Martijn M. Stuiver, Maaike W. van de Kamp, Jolanda Bloos ‐ van der Hulst, Laura S. Mertens, Kees Hendricksen, Wim H. van Harten, Anne M. May, Maike G. Sweegers   +8 more
wiley   +1 more source

Outcomes of radical cystectomy in a resource-limited setting: a pilot study. [PDF]

BMC Urol
Taha SM, Abdallah AA, Osman YM, Taha MM, Elhassan MMA, Ahmed MEIM.   +5 more
europepmc   +1 more source

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why

, 2000
Richard Sylvester, Cora N. Sternberg
openalex   +1 more source

256: The Significance of Frozen Section Ureteral Abnormalities at Time of Cystectomy [PDF]

, 2004
William C. Huang, Ricardo Sánchez‐Ortiz, Elizabeth M. Genega, S. Bruce Malkowicz   +3 more
openalex   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review

British Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.
Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis, Andreas Papapetropoulos, Steve P. H. Alexander, Miriam Cortese‐Krott, Dave A. Kendall, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Mauro M. Teixeira, Nathalie Vergnolle, Xin Wang, Péter Ferdinandy   +16 more
wiley   +1 more source

Preoperative Concurrent Chemoradiotherapy Against Muscle-invasive Bladder Cancer: Results of Partial Cystectomy in Elderly or High-risk Patients

, 2000
Yukio Kageyama
openalex   +1 more source

Laparoscopic partial cystectomy in bladder cancer: initial experience [PDF]

, 2004
Mirandolino Batista Mariano, Marcos V. Tefilli   +1 more
openalex   +1 more source

The endometrioma paradox. [PDF]

JBRA Assist Reprod
Dias JA, Izzo CR, Fassolas G, Henrique LFO, Maciel GAR, Podgaec S, Delamuta LC.   +6 more
europepmc   +1 more source